P2.04-20 Immunologic Characterization of Fibrinous Pericarditis as an Immune Checkpoint Blockade Toxicity in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immune Checkpoint Blockade in Lymphoid Malignancies

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Bread and Butter Fibrinous Pericarditis

Autopsy and Case Reports
2016English

A Case of Rheumatic Fibrinous Pericarditis

Circulation. Cardiovascular imaging
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2016English

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Cancer immunology research
Cancer ResearchImmunology
2015English

P3.04-20 Correlation of Immune-Related Adverse Events and Response From Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Checkpoint Blockade: Subjugation of the Masses

2017English

P2.04-09 Driver Mutations Are Associated With Distinct Patterns of Response to Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.04-21 Real World Experience of Immune Checkpoint Inhibitors in NSCLC: Our First 10 Months Experience at Leeds Cancer Centre, UK

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy